D P Carbone Selected Research

Interleukin-4 Receptors (Interleukin 4 Receptor)

12/2000

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D P Carbone Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 05/2000
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2001
4	Lung Neoplasms (Lung Cancer) 11/2005 - 05/2000
2	Carcinogenesis 07/2005 - 01/2001
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Adenocarcinoma of Lung 11/2005
1	Stomach Neoplasms (Stomach Cancer) 05/2005
1	Colonic Neoplasms (Colon Cancer) 07/2001
1	Lymphatic Metastasis 07/2001
1	Colorectal Neoplasms (Colorectal Cancer) 07/2001
1	Hypersensitivity (Allergy) 06/2001
1	Squamous Cell Carcinoma of Head and Neck 03/2001
1	Malaria 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

3	Transforming Growth Factor beta (TGF-beta)IBA 11/2005 - 05/2000
3	Proteins (Proteins, Gene)FDA Link 07/2005 - 01/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2001 - 05/2000
2	NivolumabIBA 12/2021 - 10/2021
2	IpilimumabIBA 12/2021 - 10/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 01/2010
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2010
1	Insulin-Like PeptidesIBA 05/2005
1	Amino Acids FDA Link 05/2005
1	Therapeutic UsesIBA 05/2005
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2005
1	LigandsIBA 05/2005
1	SurvivinIBA 08/2004
1	Biomarkers (Surrogate Marker)IBA 08/2004
1	Glycoproteins (Glycoprotein)IBA 07/2001
1	Insulin-Like Growth Factor Binding ProteinsIBA 07/2001
1	tumor-derived adhesion factorIBA 07/2001
1	Immunoglobulin E (IgE)IBA 06/2001
1	IgE Receptors (Fc epsilon RI)IBA 06/2001
1	NF-kappa B (NF-kB)IBA 03/2001
1	Phosphotransferases (Kinase)IBA 03/2001
1	Transcription Factors (Transcription Factor)IBA 03/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2001
1	CarcinogensIBA 01/2001
1	Biological ProductsIBA 01/2001
1	Cisplatin (Platino)FDA LinkGeneric 01/2001
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2001
1	Interleukin-4 (Interleukin 4)IBA 12/2000
1	CytokinesIBA 12/2000
1	Radiation-Sensitizing AgentsIBA 12/2000
1	texaphyrinIBA 12/2000
1	GadoliniumIBA 12/2000
1	Interleukin-13IBA 12/2000
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2000
1	STAT6 Transcription FactorIBA 12/2000
1	Interleukin-10 (Interleukin 10)IBA 05/2000
1	Endothelial Growth FactorsIBA 05/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2000
1	AntibodiesIBA 05/2000
1	Interleukin-6 (Interleukin 6)IBA 05/2000
1	Macrophage Colony-Stimulating FactorIBA 05/2000
1	Blocking AntibodiesIBA 01/2000
1	EpitopesIBA 01/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2021 - 05/2005
3	Therapeutics 01/2021 - 05/2000
2	Immunotherapy 01/2001 - 12/2000
1	Radiotherapy 03/2001
1	Rejuvenation 01/2001